Senate Markup Would Give NCI $985 Million, Offers Prospect That Reductions In Grants Will Be Restored
In Brief: Kennedy To Stay On Health Committee; Animal Research Bills Probably Dead For This Congress
Senate Committee Blocks Effort To Overturn Organ Systems Changes
New NCAB Weak In Grant Reviews, Confused By Issues
Final Issues Of 1982
Announcement, RFA On Drug Discovery Groups Coming
Steiner To Leave ICC, Says Someone Else May Do Better
NCI Buys Building For PDQ, ICRDB With Donated Money
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - Brian Wolpin celebrates FDA approval of daraxonrasib in pancreatic cancer as the future of the field
- The end of “more money, more people, more trials”
Cancer centers are being asked to grow their portfolios on flat budgets. Headcount is the wrong answer. - Harold Freeman, a surgeon who championed health equity, dies at 93
Freeman, the father of patient navigation, served as president of ACS and chair of the President’s Cancer Panel - The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish
